These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19051592)

  • 1. Solubility of selected derivatives of 1,4-benzodiazepine-2-one in the presence of PVP.
    Cwiertnia B
    Acta Pol Pharm; 2008; 65(4):487-91. PubMed ID: 19051592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubility of selected derivatives of 1,4-benzodiazepin-2-one in solid dispersions in PEG 6000.
    Cwiertnia B
    Acta Pol Pharm; 2006; 63(2):135-9. PubMed ID: 17514877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques.
    van Drooge DJ; Hinrichs WL; Visser MR; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):220-9. PubMed ID: 16427226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets.
    Srinarong P; Kouwen S; Visser MR; Hinrichs WL; Frijlink HW
    Pharm Dev Technol; 2010; 15(5):460-8. PubMed ID: 20735300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preparation and characterization of solid dispersions of ginkgolides].
    Ma L; Han L; Zhang Z; Wang J
    Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(11):1368-72. PubMed ID: 19771864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugs.
    Van den Mooter G; Weuts I; De Ridder T; Blaton N
    Int J Pharm; 2006 Jun; 316(1-2):1-6. PubMed ID: 16563676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
    Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
    Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improvement in physicochemical properties of carvedilol through spherically agglomerated solid dispersions with PVP K30.
    Tapas A; Kawtikwar P; Sakarkar D
    Acta Pol Pharm; 2012; 69(2):299-308. PubMed ID: 22568045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissolution kinetics for coprecipitates of diflunisal with PVP K30.
    Rodríguez-Espinosa C; Martínez-Ohárriz MC; Martín C; Goñi MM; Vélaz I; Sánchez M
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):109-12. PubMed ID: 9725466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of physical properties of troglitazone crystal on the molecular interaction with PVP during heating.
    Hasegawa S; Furuyama N; Yada S; Hamaura T; Kusai A; Yonemochi E; Terada K
    Int J Pharm; 2007 May; 336(1):82-9. PubMed ID: 17178201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HyperDSC studies of amorphous polyvinylpyrrolidone in a model wet granulation system.
    Buckton G; Adeniyi AA; Saunders M; Ambarkhane A
    Int J Pharm; 2006 Apr; 312(1-2):61-5. PubMed ID: 16500057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraorally fast-dissolving particles of a poorly soluble drug: preparation and in vitro characterization.
    Laitinen R; Suihko E; Toukola K; Björkqvist M; Riikonen J; Lehto VP; Järvinen K; Ketolainen J
    Eur J Pharm Biopharm; 2009 Feb; 71(2):271-81. PubMed ID: 18824096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interaction between macromolecular adjuvants and drugs. 24. Improvement of the solubility characteristics of benzodiazepine derivatives with polyvinylpyrrolidone].
    Keipert S; Voigt R
    Pharmazie; 1986 Jun; 41(6):400-4. PubMed ID: 2876444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and dissolution property of ipriflavone solid dispersion.
    Li YP; Zhang XY; Zhou JJ; Pei YY
    Zhongguo Yao Li Xue Bao; 1999 Oct; 20(10):957-60. PubMed ID: 11271000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binary and ternary inclusion complexes of finasteride in HPbetaCD and polymers: preparation and characterization.
    Asbahr AC; Franco L; Barison A; Silva CW; Ferraz HG; Rodrigues LN
    Bioorg Med Chem; 2009 Apr; 17(7):2718-23. PubMed ID: 19282187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
    Patil MP; Gaikwad NJ
    Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interaction between macromolecular adjuvants and drugs. 25. The effect of cellulose ether on the solubility characteristics of benzodiazepine derivatives].
    Keipert S; Alde D
    Pharmazie; 1986 Dec; 41(12):845-9. PubMed ID: 2883673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid dispersion of quercetin in cellulose derivative matrices influences both solubility and stability.
    Li B; Konecke S; Harich K; Wegiel L; Taylor LS; Edgar KJ
    Carbohydr Polym; 2013 Feb; 92(2):2033-40. PubMed ID: 23399255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid-state interaction of stearic acid with povidone and its effect on dissolution stability of capsules.
    Desai D; Kothari S; Huang M
    Int J Pharm; 2008 Apr; 354(1-2):77-81. PubMed ID: 18194844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.